Treatment of High Blood Pressure in Patients with Chronic Renal Disease

Adina Măndiţă, Delia Timofte, Andra-Elena Balcangiu‐Stroescu, Daniela Bălan, Laura Răducu, Maria Daniela Tănăsescu, Alexandru Diaconescu, Dorin Dragoș, Cristina-Ileana Cosconel, Silvia Maria Stoicescu,

Revista de Chimie · 2019 · 20 citations · 0 references

DOIFull text

Open access

Concepts

Abstract

The treatment of HTA plays a central part in the management of Chronic Kidney Disease (CKD) in all its stages, especially in patients following a substitute treatment of renal functions. HBP can be both the cause and the consequence of CKD. The HBP control in CKD patients represents one of the most important concerns of clinicians. HBP treatment is non pharmacological as well as pharmacological.